CoChat

Treatment for Substance Use Disorder With Co-Occurring Mental Illness

Open access

The DOI matches its Crossref record; 168 of the 169 references it cites were found in a registry or an index.

Abstract

Substance use disorder is a highly prevalent condition, leading to significant morbidity, mortality, and burden on the health care system. Substance use disorders are overrepresented among individuals with a mental illness. The term "dual diagnosis" was introduced by the World Health Organization in the mid-1990s and refers to the co-occurrence of a substance use disorder with mental illness-a more recently used term is "co-occurring disorders." In the past decade, substantial progress has been made toward expanding psychotherapeutic and pharmacotherapeutic treatments for treating co-occurring disorders. Yet management remains a challenge among clinicians and has been a source of confusion and considerable controversy. This review describes the epidemiology and treatment of co-occurring disorders, with a focus on major depressive disorder, anxiety disorders, and attention-deficit hyperactivity disorder. Substance use may make diagnosis of the underlying psychiatric condition difficult, and a period of abstinence may be necessary. Findings from efficacy studies of medications used to treat co-occurring disorders are reviewed, as are results of preliminary studies of newer treatments, such as topiramate, ketamine, noninvasive brain stimulation, and deep brain stimulation. Treatment recommendations that combine medications and psychosocial interventions are summarized.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.focus.20180042

Cites

168 of 168 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 6

  1. Centers for Disease Control and Prevention (CDC), 2010, Morb Mortal Wkly Rep, 59, 1229
  2. Hasin DS, 1998, Drug Alcohol Depend, 39, 197
  3. 10.1111/j.1530-0277.2000.tb04648.x · doi:10.1111/j.1530-0277.2000.tb04648.x · Paper page
  4. 10.1037/0893-164X.7.4.211 · DOI · Paper page
  5. Niciu MJ, 2014, Int J Neuropsychopharmacol, 18, pyu039
  6. Rapinesi C, 2013, Prim Care Companion CNS Disord, 15, PCC.12m01438

Cited by

See all 66

Metadata

Authors
Iqbal, M. N., Levin, C. J., & Levin, F. R.
Affiliations
New York State Psychiatric Institute (US)
Venue
Focus
Published
2019-04
Volume
17
Issue
2
Pages
88-97
ISSN
  • 1541-4094 (ISSN-L)
  • 1541-4108
OpenAlex
W2938661501
Cited by
66
References
169
Citations by year
2026: 9 · 2025: 11 · 2024: 14 · 2023: 10 · 2022: 5 · 2021: 11 · 2020: 4 · 2019: 2
FWCI
0.80
Type
journal article
Language
en
Open access
Locations
  • FOCUS The Journal of Lifelong Learning in Psychiatry (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Drug Abuse (K24DA029647, T32DA007294)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
substance use disorders, co-occurring disorders, dual diagnosis, major depressive disorder, anxiety disorders, attention deficit hyperactivity disorder, pharmacotherapy, psychotherapy, topiramate, ketamine, non-invasive brain stimulation, deep brain stimulation, abstinence, comorbidities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.